New therapy for central retinal vein occlusion: are intravitreal steroids a possible answer?
Blumenkranz
Mark S
MS
Department of Ophthalmology, Stanford University Medical Center, CA 94305, USA. mark.blumenkranz@stanford.edu
D002986:Clinical Trials as Topic; D005938:Glucocorticoids / Q000627:therapeutic use*; D006801:Humans; D012170:Retinal Vein Occlusion / Q000188:drug therapy*; D014822:Vitreous Body
D005938:Glucocorticoids